Myriam Boeck
Overview
Explore the profile of Myriam Boeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boeck M, Yagi H, Chen C, Zeng Y, Lee D, Nian S, et al.
J Adv Res
. 2025 Mar;
PMID: 40049514
Introduction: Dyslipidemia contributes to many retinal diseases, but underlying lipid processing pathways are not fully understood. Peroxisomes oxidize very long-chain fatty acids and generate docosahexaenoic acid (DHA). Mutations in peroxisomal...
2.
Nian S, Zeng Y, Heyden K, Cagnone G, Yagi H, Boeck M, et al.
Biomolecules
. 2025 Feb;
15(2).
PMID: 40001612
Background: Retinopathy of prematurity (ROP) is the major cause of blindness in children. It is a biphasic disease with retinal vessel growth cessation and loss (Phase I) followed by uncontrolled...
3.
Yagi H, Boeck M, Nian S, Neilsen K, Wang C, Lee J, et al.
Angiogenesis
. 2024 Oct;
27(4):701-702.
PMID: 39425886
No abstract available.
4.
Yagi H, Boeck M, Petrishka-Lozenska M, Lundgren P, Kasai T, Cagnone G, et al.
Angiogenesis
. 2024 Sep;
27(4):903-917.
PMID: 39287727
Pathological neovascularization in retinopathy of prematurity (ROP) can cause visual impairment in preterm infants. Current ROP treatments which are not preventative and only address late neovascular ROP, are costly and...
5.
Yagi H, Boeck M, Nian S, Neilsen K, Wang C, Lee J, et al.
Angiogenesis
. 2024 Aug;
27(4):691-699.
PMID: 39096357
Objective: Pathological retinal neovascularization is vision-threatening. In mouse oxygen-induced retinopathy (OIR) we sought to define mitochondrial respiration changes longitudinally during hyperoxia-induced vessel loss and hypoxia-induced neovascularization, and to test interventions...
6.
Yagi H, Boeck M, Petrishka-Lozenska M, Lundgren P, Kasai T, Cagnone G, et al.
Res Sq
. 2024 Jul;
PMID: 38978601
Pathological neovascularization in retinopathy of prematurity (ROP) can cause visual impairment in preterm infants. Current ROP treatments which are not preventative and only address late neovascular ROP, are costly and...
7.
Pauleikhoff L, Boneva S, Boeck M, Schlecht A, Schlunck G, Agostini H, et al.
Invest Ophthalmol Vis Sci
. 2023 Dec;
64(15):46.
PMID: 38153746
Purpose: Retinal neovascularization (RNV) is the leading cause of vision loss in diseases like proliferative diabetic retinopathy (PDR). A significant failure rate of current treatments indicates the need for novel...
8.
Kamat V, Grumbine M, Bao K, Mokate K, Khalil G, Cook D, et al.
Cell Rep Methods
. 2023 Nov;
3(11):100642.
PMID: 37963464
To address the needs of the life sciences community and the pharmaceutical industry in pre-clinical drug development to both maintain and continuously assess tissue metabolism and function with simple and...
9.
Harman J, Pivodic A, Nilsson A, Boeck M, Yagi H, Neilsen K, et al.
iScience
. 2023 Oct;
26(10):108021.
PMID: 37841591
Nutritional deprivation occurring in most preterm infants postnatally can induce hyperglycemia, a significant and independent risk factor for suppressing physiological retinal vascularization (Phase I retinopathy of prematurity (ROP)), leading to...
10.
Zhang P, Schlecht A, Wolf J, Boneva S, Laich Y, Koch J, et al.
J Neuroinflammation
. 2021 Sep;
18(1):215.
PMID: 34544421
Background: Microglia cells represent the resident innate immune cells of the retina and are important for retinal development and tissue homeostasis. However, dysfunctional microglia can have a negative impact on...